Bruker (BRKR) Shareholder's Equity Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.20% |
| Dec 31, 2025 | 30.01% |
| Sep 30, 2025 | 36.89% |
| Jun 30, 2025 | 22.72% |
| Mar 31, 2025 | 21.13% |
| Dec 31, 2024 | 18.33% |
| Sep 30, 2024 | 18.76% |
| Jun 30, 2024 | 21.18% |
| Mar 31, 2024 | 13.43% |
| Dec 31, 2023 | 12.70% |
| Sep 30, 2023 | 8.43% |
| Jun 30, 2023 | 11.32% |
| Mar 31, 2023 | 9.04% |
| Dec 31, 2022 | 7.07% |
| Sep 30, 2022 | 3.51% |
| Jun 30, 2022 | 4.20% |
| Mar 31, 2022 | 3.82% |
| Dec 31, 2021 | 6.22% |
| Sep 30, 2021 | 9.71% |
| Jun 30, 2021 | 8.94% |
| Mar 31, 2021 | 7.50% |
| Dec 31, 2020 | 9.93% |
| Sep 30, 2020 | 9.17% |
| Jun 30, 2020 | 5.91% |
| Mar 31, 2020 | 8.46% |
| Dec 31, 2019 | 9.78% |
| Sep 30, 2019 | 6.84% |
| Jun 30, 2019 | 9.47% |
| Mar 31, 2019 | 9.49% |
| Dec 31, 2018 | 7.29% |
| Sep 30, 2018 | 2.77% |
| Jun 30, 2018 | 0.77% |
| Mar 31, 2018 | 3.36% |
| Dec 31, 2017 | -1.68% |
| Sep 30, 2017 | -3.10% |
| Jun 30, 2017 | -4.65% |
| Mar 31, 2017 | -5.85% |
| Dec 31, 2016 | -6.58% |
| Sep 30, 2016 | -3.53% |
| Jun 30, 2016 | -2.82% |
| Mar 31, 2016 | 0.62% |
| Dec 31, 2015 | 1.08% |
| Sep 30, 2015 | 3.15% |
| Jun 30, 2015 | 6.31% |
| Mar 31, 2015 | 2.82% |
| Dec 31, 2014 | 7.29% |
| Sep 30, 2014 | 10.47% |
| Jun 30, 2014 | 11.95% |
| Mar 31, 2014 | 14.96% |
| Dec 31, 2013 | 17.25% |
| Dec 31, 2012 | 19.22% |